Brief: Medincell: Product Portfolio Progresses Well Amid COVID-19 Pandemic
April 23 (Reuters) - MEDINCELL SA MEDCL.PA :
* MEDINCELL: ADAPT AND OVERCOME IN RESPONSE TO THE COVID-19
CRISIS
* SOLID FINANCIAL VISIBILITY
* PRODUCT PORTFOLIO PROGRESSES WELL
Source text for Eikon: ID:nBw2fH1T0a
Further company coverage: MEDCL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))